Citations for
1CDH5, FABP1
Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury.
Mikus M, Drobin K, Gry M, Bachmann J, Lindberg J, Yimer G, Aklillu E, Makonnen E, Aderaye G, Roach J, Fier I, Kampf C, Gpfert J, Perazzo H, Poynard T, Stephens C, Andrade RJ, Lucena MI, Arber N, Uhln M, Watkins PB, Schwenk JM, Nilsson P, Schuppe-Koistinen I.
Liver Int 37(1):132-140. doi: 10.1111/liv.13174. Epub 2016 Jun 22. 2017
2ADAM10, CDH5, TSPAN17, TSPAN5
ADAM10-Interacting Tetraspanins Tspan5 and Tspan17 Regulate VE-Cadherin Expression and Promote T Lymphocyte Transmigration.
Reyat JS, Chimen M, Noy PJ, Szyroka J, Rainger GE, Tomlinson MG.
J Immunol 199(2):666-676. doi: 10.4049/jimmunol.1600713. Epub 2017 Jun 9. 2017
3CDH5, CGNL1
Cgnl1, an endothelial junction complex protein, regulates GTPase mediated angiogenesis.
Chrifi I, Hermkens D, Brandt MM, van Dijk CGM, Brgisser PE, Haasdijk R, Pei J, van de Kamp EHM, Zhu C, Blonden L, Kros JM, Duncker DJ, Duckers HJ, Cheng C.
Cardiovasc Res 113(14):1776-1788. doi: 10.1093/cvr/cvx175. 2017
4CDH5, GPSM2
VE-Cadherin Phosphorylation Regulates Endothelial Fluid Shear Stress Responses through the Polarity Protein LGN.
Conway DE, Coon BG, Budatha M, Arsenovic PT, Orsenigo F, Wessel F, Zhang J, Zhuang Z, Dejana E, Vestweber D, Schwartz MA.
Curr Biol 27(14):2219-2225.e5. doi: 10.1016/j.cub.2017.06.020. Epub 2017 Jul 14. Erratum in: Curr Biol. 2017 Sep 11;27(17):2727. 2017
5CDH5, CMTM3
CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
Chrifi I, Louzao-Martinez L, Brandt M, van Dijk CGM, Burgisser P, Zhu C, Kros JM, Duncker DJ, Cheng C.
Arterioscler Thromb Vasc Biol 37(6):1098-1114. doi: 10.1161/ATVBAHA.116.308792. Epub 2017 Apr 20. 2017
6CDH5, PACSIN2
The F-BAR protein pacsin2 inhibits asymmetric VE-cadherin internalization from tensile adherens junctions.
Dorland YL, Malinova TS, van Stalborch AM, Grieve AG, van Geemen D, Jansen NS, de Kreuk BJ, Nawaz K, Kole J, Geerts D, Musters RJ, de Rooij J, Hordijk PL, Huveneers S.
Nat Commun 7:12210. doi: 10.1038/ncomms12210. 2016
7CDH5, CTNNB1
The RNA-binding protein quaking maintains endothelial barrier function and affects VE-cadherin and β-catenin protein expression.
de Bruin RG, van der Veer EP, Prins J, Lee DH, Dane MJ, Zhang H, Roeten MK, Bijkerk R, de Boer HC, Rabelink TJ, van Zonneveld AJ, van Gils JM.
Sci Rep 6:21643. doi: 10.1038/srep21643. 2016
8CDH5, PALS1, PARD3
VE-cadherin interacts with cell polarity protein Pals1 to regulate vascular lumen formation.
Brinkmann BF, Steinbacher T, Hartmann C, Kummer D, Pajonczyk D, Mirzapourshafiyi F, Nakayama M, Weide T, Gerke V, Ebnet K.
Mol Biol Cell. Sep 15;27(18):2811-21. doi: 10.1091/mbc.E16-02-0127. Epub 2016 Jul 27. 2016
9CCDC88A, CDH5, RRAS
Girdin/GIV regulates transendothelial permeability by controlling VE-cadherin trafficking through the small GTPase, R-Ras.
Ichimiya H, Maeda K, Enomoto A, Weng L, Takahashi M, Murohara T.
Biochem Biophys Res Commun 461(2):260-7. doi: 10.1016/j.bbrc.2015.04.012. Epub 2015 Apr 11. 2015
10CDH5, RAC1, TRIO
A local VE-cadherin and Trio-based signaling complex stabilizes endothelial junctions through Rac1.
Timmerman I, Heemskerk N, Kroon J, Schaefer A, van Rijssel J, Hoogenboezem M, van Unen J, Goedhart J, Gadella TW Jr, Yin T, Wu Y, Huveneers S, van Buul JD.
J Cell Sci 128(16):3041-54. doi: 10.1242/jcs.168674. Epub 2015 Jun 26. Erratum in: J Cell Sci. 2015 Sep 15;128(18):3514. 2015
11CDH5, EPS8, YAP1
The actin-binding protein EPS8 binds VE-cadherin and modulates YAP localization and signaling.
Giampietro C, Disanza A, Bravi L, Barrios-Rodiles M, Corada M, Frittoli E, Savorani C, Lampugnani MG, Boggetti B, Niessen C, Wrana JL, Scita G, Dejana E.
J Cell Biol 211(6):1177-92. doi: 10.1083/jcb.201501089. Epub 2015 Dec 14. 2015
12CDH5
Endothelial permeability and VE-cadherin: a wacky comradeship.
Gavard J.
Cell Adh Migr 8(2):158-64. Review. 2014
13CDH5
Cdh5/VE-cadherin promotes endothelial cell interface elongation via cortical actin polymerization during angiogenic sprouting.
Sauteur L, Krudewig A, Herwig L, Ehrenfeuchter N, Lenard A, Affolter M, Belting HG.
Cell Rep 9(2):504-13. doi: 10.1016/j.celrep.2014.09.024. Epub 2014 Oct 16. 2014
14AMOTL2, CDH5
AmotL2 links VE-cadherin to contractile actin fibres necessary for aortic lumen expansion.
Hultin S, Zheng Y, Mojallal M, Vertuani S, Gentili C, Balland M, Milloud R, Belting HG, Affolter M, Helker CS, Adams RH, Herzog W, Uhlen P, Majumdar A, Holmgren L.
Nat Commun 5:3743. doi: 10.1038/ncomms4743. 2014
15CDH5, CHRM3, IQGAP1, RAC1
M3 muscarinic acetylcholine receptor dysfunction inhibits Rac1 activity and disrupts VE-cadherin/β-catenin and actin cytoskeleton interaction.
Jiao ZY, Wu J, Wen B, Zhao WZ, Du XL.
Biochem Cell Biol 92(2):137-44. doi: 10.1139/bcb-2013-0042. Epub 2014 Jan 8. 2014
16CDH5, CTNNB1, CTNND1
p120-catenin and β-catenin differentially regulate cadherin adhesive function.
Oas RG, Nanes BA, Esimai CC, Vincent PA, Garca AJ, Kowalczyk AP.
Mol Biol Cell 24(6):704-14. doi: 10.1091/mbc.E12-06-0471. Epub 2013 Jan 16. 2013
17CDH5
VE-cadherin status as an indicator of microvascular permeability.
Monaghan-Benson E, Burridge K.
Methods Mol Biol 1046:335-42. doi: 10.1007/978-1-62703-538-5_20. 2013
18CDH5, CLDN5, NECTIN2
Human chorionic gonadotropin controls luteal vascular permeability via vascular endothelial growth factor by down-regulation of a cascade of adhesion proteins.
Herr D, Fraser HM, Konrad R, Holzheu I, Kreienberg R, Wulff C.
Fertil Steril 99(6):1749-58. doi: 10.1016/j.fertnstert.2013.01.120. Epub 2013 Mar 7. 2013
19CDH5
Vinculin associates with endothelial VE-cadherin junctions to control force-dependent remodeling.
Huveneers S, Oldenburg J, Spanjaard E, van der Krogt G, Grigoriev I, Akhmanova A, Rehmann H, de Rooij J.
J Cell Biol 196(5):641-52. 2012
20CDH5
Vascular endothelial cadherin modulates renal interstitial fibrosis.
Yamaguchi I, Tchao BN, Burger ML, Yamada M, Hyodo T, Giampietro C, Eddy AA.
Nephron Exp Nephrol 120(1):e20-31. Epub 2011 Nov 25. 2012
21CDH5, SOX7
SOX7 regulates the expression of VE-cadherin in the haemogenic endothelium at the onset of haematopoietic development.
Costa G, Mazan A, Gandillet A, Pearson S, Lacaud G, Kouskoff V.
Development 139(9):1587-98. 2012
22CDH5, CTNNB1, PTPN11
The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of β-catenin phosphorylation.
Timmerman I, Hoogenboezem M, Bennett AM, Geerts D, Hordijk PL, van Buul JD.
Mol Biol Cell 23(21):4212-25. doi: 10.1091/mbc.E12-01-0038. Epub 2012 Sep 5. 2012
23CDH5, MAPRE3
VE-cadherin signaling induces EB3 phosphorylation to suppress microtubule growth and assemble adherens junctions.
Komarova YA, Huang F, Geyer M, Daneshjou N, Garcia A, Idalino L, Kreutz B, Mehta D, Malik AB.
Mol Cell 48(6):914-25. doi: 10.1016/j.molcel.2012.10.011. Epub 2012 Nov 15. 2012
24CDH5, JCAD
A coronary artery disease-associated gene product, JCAD/KIAA1462, is a novel component of endothelial cell-cell junctions.
Akashi M, Higashi T, Masuda S, Komori T, Furuse M.
Biochem Biophys Res Commun 413(2):224-9. Epub 2011 Aug 22. 2011
25CDH5, CTNNA1
Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability.
Schulte D, Kppers V, Dartsch N, Broermann A, Li H, Zarbock A, Kamenyeva O, Kiefer F, Khandoga A, Massberg S, Vestweber D.
EMBO J 30(20):4157-70. doi: 10.1038/emboj.2011.304. 2011
26CDH5
Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation.
Hatanaka K, Simons M, Murakami M.
Am J Physiol Heart Circ Physiol 300(1):H162-72. Epub 2010 Oct 29. 2011
27CDH5, CEACAM1, PECAM1
Angiopoietins-1 and -2 play opposing roles in endothelial sprouting of embryoid bodies in 3D culture and their receptor Tie-2 associates with the cell-cell adhesion molecule PECAM1.
Gu A, Shively JE.
Exp Cell Res 317(15):2171-82. Epub 2011 Jun 23. 2011
28CDH5, KLF4
Kruppel-like factor-4 transcriptionally regulates VE-cadherin expression and endothelial barrier function.
Cowan CE, Kohler EE, Dugan TA, Mirza MK, Malik AB, Wary KK.
Circ Res 107(8):959-66. Epub 2010 Aug 19. 2010
29CDH5, PECAM1
VE-cadherin and PECAM-1 enhance ALL migration across brain microvascular endothelial cell monolayers.
Akers SM, O'Leary HA, Minnear FL, Craig MD, Vos JA, Coad JE, Gibson LF.
Exp Hematol 38(9):733-43. Epub 2010 May 12. 2010
30CDH5
Differential expression of VE-cadherin and VEGFR2 in placental syncytiotrophoblast during preeclampsia - New perspectives to explain the pathophysiology.
Groten T, Gebhard N, Kreienberg R, Schleussner E, Reister F, Huppertz B.
Placenta 31(4):339-43. Epub 2010 Feb 18. 2010
31CDH5
VE-Cadherin-mediated cell-cell interaction suppresses sprouting via signaling to MLC2 phosphorylation.
Abraham S, Yeo M, Montero-Balaguer M, Paterson H, Dejana E, Marshall CJ, Mavria G.
Curr Biol 19(8):668-74. Epub 2009 Apr 2. 2009
32CDH5
Breaking the VE-cadherin bonds.
Gavard J.
FEBS Lett 583(1):1-6. Epub 2008 Dec 4. Review. 2009
33CDH5
Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
Labelle M, Schnittler HJ, Aust DE, Friedrich K, Baretton G, Vestweber D, Breier G.
Cancer Res 68(5):1388-97. 2008
34VEGFA, CDH5
A novel role of vascular endothelial cadherin in modulating c-Src activation and downstream signaling of vascular endothelial growth factor.
Ha CH, Bennett AM, Jin ZG.
J Biol Chem 283(11):7261-70. Epub 2008 Jan 7. 2008
35CDH5
VE-cadherin is a critical endothelial regulator of TGF-beta signalling.
Rudini N, Felici A, Giampietro C, Lampugnani M, Corada M, Swirsding K, Garr M, Liebner S, Letarte M, ten Dijke P, Dejana E.
EMBO J 27(7):993-1004. Epub 2008 Mar 13. 2008
36CDH5, CLDN5
Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5.
Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, Pirazzoli V, Potente M, Daly C, Dimmeler S, Dejana E.
Nat Cell Biol 10(8):923-34. Epub 2008 Jul 6. 2008
37CSK, CDH5
Association of Csk to VE-cadherin and inhibition of cell proliferation.
Baumeister U, Funke R, Ebnet K, Vorschmitt H, Koch S, Vestweber D.
EMBO J 24(9):1686-95. Epub 2005 Apr 7. 2005
38CDH5
CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system.
Thompson PM, Gotoh T, Kok M, White PS, Brodeur GM.
Oncogene 22(7):1002-11. 2003
39CDH5, CHD6
CHD5 defines a new subfamily of chromodomain-SWI2/SNF2-like helicases.
Schuster EF, Stoger R.
Mamm Genome 13(2):117-9. No abstract available. 2002
40CDH1, CDH10, CDH11, CDH12, CDH12P, CDH13, CDH15, CDH16, CDH17, CDH18, CDH19, CDH2, CDH20, CDH23, CDH3, CDH4, CDH5, CDH6, CDH7, CDH8, CDH9, PCDH11Y, PCDHA@, PCDHA1, PCDHA10, PCDHA11, PCDHA12, PCDHA13, PCDHA14, PCDHA2, PCDHA3, PCDHA4, PCDHA5, PCDHA6, PCDHA7, PCDHA8, PCDHA9, PCDHACT, PCDHB1, PCDHB10, PCDHB11, PCDHB12, PCDHB13, PCDHB14, PCDHB15, PCDHB16, PCDHB2, PCDHB3, PCDHB4, PCDHB5, PCDHB6, PCDHB7, PCDHB8, PCDHB9, PCDHAC1, PCDHAC2, PCDHGA1, PCDHGA10, PCDHGA11, PCDHGA12, PCDHGA2, PCDHGA3, PCDHGA4, PCDHGA5, PCDHGA6, PCDHGA7, PCDHGA8, PCDHGA9, PCDHGB1, PCDHGB2, PCDHGB3, PCDHGB4, PCDHGB5, PCDHGB6, PCDHGB7, PCDHGC3, PCDHGC4, PCDHGC5, PCDHGCT
Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.
Nollet F, Kools P, van Roy F.
J Mol Biol 299(3):551-72. Review. 2000
41CDH19, CDH15, CDH12, CDH10, CDH9, CDH8, CDH7, CDH7, CDH6, CDH5, CDH18
Identification of three human type-II classic cadherins and frequent heterophilic interactions between different subclasses of type-II classic cadherins.
Shimoyama Y, Tsujimoto G, Kitajima M, Natori M.
Biochem J 349(Pt 1):159-67. 2000
42CDH5
Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo.
Corada M, et al.
Proc Natl Acad Sci U S A 96(17):9815-20 1999
43CDH3, CDH5, CDH6, CDH7, CDH8, CDH11, CDH13, CDH15, CDH17
Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity.
Kremmidiotis G, et al.
Genomics 49 : 467-471. 1998
44CDH5
Diversity of the cadherin family : evidence for eight new cadherins in nervous tissue.
Suzuki S, et al.
Cell Regul 2 : 261-270. 1991